← All stocks

Krystal Biotech, Inc.

KRYS Net selling
CIK 0001711279 #938 in the set updated 17 Sep 2026
Bought (12 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$105.27M
$74.52M on a plan · $22.53M straight out of an exercise
Sold at will
$8.23M
8 of 142 sales
Net
−$105.27M
−$8.23M against sales at will

By person

6 insiders · 142 transactions
1,296×

Krish S. Krishnan holds 1,296 times base salary in stock. $1.10B of shares against $846.17K in salary for 2025.

Salary from the company's own proxy. The shares are what Krish S. Krishnan last reported holding, valued at $366.56, the price Common Stock was last bought or sold at on the open market here, on 4 Sep 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Krishnan Suma
President, R&D
$34.27M (50) scheduled
−$34.27M
2,993,408
10.11%
$1.10B
−6.5%
Krishnan Krish S
President and CEO
$34.27M (50) scheduled
−$34.27M
2,993,408
10.11%
$1.10B
−6.5%
JANNEY DANIEL
Director
$19.40M (22) scheduled
−$19.40M
73,293
0.2476%
$26.87M
−31.7%
ROSSI DINO A
Director
$13.18M (10)
−$13.18M
50,000
0.1689%
$18.33M
−36.5%
ROMANO KATHRYN
Chief Accounting Officer
$3.60M (8) scheduled
−$3.60M
22,366
0.0756%
$8.20M
+43.2%
Thomas John Charles
EVP, General Counsel
$541.17K (2) scheduled
−$541.17K
0
0.0000%
$0.00
−100.0%
Insider
Date
Role
Action
Shares
Price
Amount
Thomas John Charles
25 Jun 2026
EVP, General Counsel
Sold after exercise
1,000
$347.27
$347.27K
JANNEY DANIEL
24 Feb 2026
Director
Sold after exercise indirect
2,425
$274.90
$666.63K
JANNEY DANIEL
24 Feb 2026
Director
Sold after exercise indirect
930
$269.50
$250.64K
JANNEY DANIEL
24 Feb 2026
Director
Sold after exercise indirect
1,674
$268.67
$449.75K
JANNEY DANIEL
24 Feb 2026
Director
Sold after exercise indirect
1,891
$267.37
$505.60K
JANNEY DANIEL
24 Feb 2026
Director
Sold after exercise indirect
4,339
$266.62
$1.16M
JANNEY DANIEL
24 Feb 2026
Director
Sold after exercise indirect
1,604
$265.54
$425.92K
JANNEY DANIEL
24 Feb 2026
Director
Sold after exercise indirect
900
$264.60
$238.14K
JANNEY DANIEL
24 Feb 2026
Director
Sold after exercise indirect
62
$263.05
$16.31K
JANNEY DANIEL
24 Feb 2026
Director
Sold after exercise
373
$271.09
$101.12K
JANNEY DANIEL
24 Feb 2026
Director
Sold after exercise
370
$269.83
$99.84K
JANNEY DANIEL
24 Feb 2026
Director
Sold after exercise
3,963
$268.97
$1.07M
JANNEY DANIEL
24 Feb 2026
Director
Sold after exercise
6,671
$268.04
$1.79M
JANNEY DANIEL
24 Feb 2026
Director
Sold after exercise
11,673
$266.97
$3.12M
JANNEY DANIEL
24 Feb 2026
Director
Sold after exercise
8,986
$266.18
$2.39M
JANNEY DANIEL
24 Feb 2026
Director
Sold after exercise
3,557
$265.08
$942.88K
JANNEY DANIEL
24 Feb 2026
Director
Sold after exercise
1,733
$264.12
$457.73K
JANNEY DANIEL
24 Feb 2026
Director
Sold after exercise
569
$262.91
$149.59K
ROSSI DINO A
19 Feb 2026
Director
Sold after exercise
10,834
$262.10
$2.84M
ROSSI DINO A
19 Feb 2026
Director
Sold after exercise
8,116
$260.49
$2.11M
ROMANO KATHRYN
9 Feb 2026
Chief Accounting Officer
Sold after exercise
96
$277.88
$26.68K
ROMANO KATHRYN
9 Feb 2026
Chief Accounting Officer
Sold after exercise
400
$275.68
$110.27K
ROMANO KATHRYN
9 Feb 2026
Chief Accounting Officer
Sold after exercise
552
$274.64
$151.60K
ROMANO KATHRYN
9 Feb 2026
Chief Accounting Officer
Sold after exercise
928
$273.71
$254.00K
ROMANO KATHRYN
9 Feb 2026
Chief Accounting Officer
Sold after exercise
2,824
$272.51
$769.56K
ROMANO KATHRYN
9 Feb 2026
Chief Accounting Officer
Sold after exercise
5,700
$271.66
$1.55M
ROMANO KATHRYN
9 Feb 2026
Chief Accounting Officer
Sold after exercise
2,000
$270.56
$541.12K

What was left out

Form 4 filings counted 24
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 107
Sales straight out of an exercise 27
Sales at will 8
Transactions with no price 0
Shares from compensation/vesting 291,956
History held since 25 Sep 2017